Relationship between lipoprotein concentrations and short-term and 1-year mortality in intensive care unit septic patients: results from the HIGHSEPS study.
High-density lipoprotein
Intensive care unit
Low-density lipoprotein
Mortality
Outcome
Sepsis
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
19 Jan 2021
19 Jan 2021
Historique:
received:
14
08
2020
accepted:
06
01
2021
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
High-density lipoproteins (HDLs), particles characterized by their reverse cholesterol transport function, display pleiotropic properties, including anti-inflammatory and antioxidant functions. Moreover, all lipoproteins (HDLs but also low-density lipoproteins (LDLs)) neutralize lipopolysaccharides, leading to increased bacterial clearance. These two lipoproteins decrease during sepsis, and an association between low lipoprotein levels and poor outcome was reported. The goals of this study were to characterize the lipid profile of septic patients hospitalized in our intensive care unit (ICU) and to determine the relationship with the outcome. A prospective observational study was conducted in a university hospital ICU. All consecutive patients admitted for septic shock or sepsis were included. Total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride levels were assessed at admission (day 1), at day 3, and at ICU discharge. When available, a prehospitalization lipid profile collected prior to the patient's hospitalization was compiled. Short-term and 1-year prognostic outcomes were prospectively assessed. A total of 205 patients were included. We found a decrease in HDL-C concentration between previous values and those at admission, followed by an additional decrease at day 3. At ICU discharge, the concentration was higher than that at day 3 but did not reach the concentration measured prior to hospitalization (prior HDL-C = 1.22 (1.04-1.57) mmol/l; day 1 HDL-C = 0.44 (0.29-0.70) mmol/l; day 3 HDL-C = 0.30 (0.25-0.48) mmol/l; and HDL-C at discharge = 0.65 (0.42-0.82) mmol/l). A similar trend was found for LDL-C (prior LDL-C = 2.7 (1.91-3.33) mmol/l; day 1 LDL-C = 1.0 (0.58-1.50) mmol/l; day 3 LDL-C = 1.04 (0.64-1.54) mmol/l; and LDL-C at discharge = 1.69 (1.26-2.21) mmol/l). Mixed models for repeated measures of lipoprotein concentrations showed a significant difference in HDL-C and LDL-C concentrations over time between survivors and nonsurvivors at day 28. An HDL-C concentration at admission of less than 0.4 mmol/l was associated with increased mortality at day 28 (log-rank test, p = 0.034) but not at 1 year (log-rank test, p = 0.24). An LDL-C concentration at admission of less than 0.72 mmol/l was associated with increased mortality at day 28 and at 1 year (log-rank test, p < 0.001 and p = 0.007, respectively). No link was found between prior lipid profile and mortality. We showed no relationship between the prehospitalization lipid profile and patient outcome, but low lipoprotein levels in the ICU were strongly associated with short-term mortality.
Sections du résumé
BACKGROUND
BACKGROUND
High-density lipoproteins (HDLs), particles characterized by their reverse cholesterol transport function, display pleiotropic properties, including anti-inflammatory and antioxidant functions. Moreover, all lipoproteins (HDLs but also low-density lipoproteins (LDLs)) neutralize lipopolysaccharides, leading to increased bacterial clearance. These two lipoproteins decrease during sepsis, and an association between low lipoprotein levels and poor outcome was reported. The goals of this study were to characterize the lipid profile of septic patients hospitalized in our intensive care unit (ICU) and to determine the relationship with the outcome.
METHODS
METHODS
A prospective observational study was conducted in a university hospital ICU. All consecutive patients admitted for septic shock or sepsis were included. Total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride levels were assessed at admission (day 1), at day 3, and at ICU discharge. When available, a prehospitalization lipid profile collected prior to the patient's hospitalization was compiled. Short-term and 1-year prognostic outcomes were prospectively assessed.
RESULTS
RESULTS
A total of 205 patients were included. We found a decrease in HDL-C concentration between previous values and those at admission, followed by an additional decrease at day 3. At ICU discharge, the concentration was higher than that at day 3 but did not reach the concentration measured prior to hospitalization (prior HDL-C = 1.22 (1.04-1.57) mmol/l; day 1 HDL-C = 0.44 (0.29-0.70) mmol/l; day 3 HDL-C = 0.30 (0.25-0.48) mmol/l; and HDL-C at discharge = 0.65 (0.42-0.82) mmol/l). A similar trend was found for LDL-C (prior LDL-C = 2.7 (1.91-3.33) mmol/l; day 1 LDL-C = 1.0 (0.58-1.50) mmol/l; day 3 LDL-C = 1.04 (0.64-1.54) mmol/l; and LDL-C at discharge = 1.69 (1.26-2.21) mmol/l). Mixed models for repeated measures of lipoprotein concentrations showed a significant difference in HDL-C and LDL-C concentrations over time between survivors and nonsurvivors at day 28. An HDL-C concentration at admission of less than 0.4 mmol/l was associated with increased mortality at day 28 (log-rank test, p = 0.034) but not at 1 year (log-rank test, p = 0.24). An LDL-C concentration at admission of less than 0.72 mmol/l was associated with increased mortality at day 28 and at 1 year (log-rank test, p < 0.001 and p = 0.007, respectively). No link was found between prior lipid profile and mortality.
CONCLUSIONS
CONCLUSIONS
We showed no relationship between the prehospitalization lipid profile and patient outcome, but low lipoprotein levels in the ICU were strongly associated with short-term mortality.
Identifiants
pubmed: 33469739
doi: 10.1186/s13613-021-00800-0
pii: 10.1186/s13613-021-00800-0
pmc: PMC7815878
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11Références
Crit Care Med. 2001 Aug;29(8):1563-8
pubmed: 11505128
Circulation. 2006 Sep 26;114(13):1403-9
pubmed: 16982942
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040-4
pubmed: 8265667
PLoS One. 2018 Sep 14;13(9):e0203813
pubmed: 30216360
Sci Transl Med. 2014 Oct 15;6(258):258ra143
pubmed: 25320235
Expert Opin Investig Drugs. 2017 Feb;26(2):137-139
pubmed: 27967260
Crit Care Med. 1996 Apr;24(4):584-9
pubmed: 8612407
Anesthesiology. 2020 Apr;132(4):825-838
pubmed: 32101976
Crit Care. 2020 Apr 7;24(1):134
pubmed: 32264946
N Engl J Med. 2010 Dec 16;363(25):2406-15
pubmed: 21082868
Biomed Res Int. 2015;2015:789298
pubmed: 26351639
Shock. 2017 Nov;48(5):539-544
pubmed: 28452909
Crit Care Med. 2003 May;31(5):1359-66
pubmed: 12771603
J Crit Care. 2017 Apr;38:289-294
pubmed: 28013095
Infect Immun. 2000 May;68(5):2410-7
pubmed: 10768924
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Shock. 2004 Mar;21(3):210-21
pubmed: 14770033
Shock. 2003 Dec;20(6):551-7
pubmed: 14625480
Biomolecules. 2020 Apr 12;10(4):
pubmed: 32290632
N Engl J Med. 2007 Nov 22;357(21):2109-22
pubmed: 17984165
J Crit Care. 2014 Oct;29(5):723-7
pubmed: 24891152
Nature. 1991 Sep 19;353(6341):265-7
pubmed: 1910153
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
N Engl J Med. 2013 Nov 21;369(21):2063
pubmed: 24256390
J Lipid Res. 2003 Dec;44(12):2339-48
pubmed: 12923224
Intensive Care Med. 2007 Jan;33(1):13-24
pubmed: 17093985
Am J Respir Crit Care Med. 2019 Apr 1;199(7):854-862
pubmed: 30321485
J Exp Med. 1994 Sep 1;180(3):1025-35
pubmed: 8064223
N Engl J Med. 2007 Apr 19;356(16):1620-30
pubmed: 17387131
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):267-278
pubmed: 31694394
Infect Immun. 2001 May;69(5):2821-8
pubmed: 11292694
Atherosclerosis. 2009 Oct;206(2):611-6
pubmed: 19375079
Clin Res Cardiol. 2008 Apr;97(4):227-33
pubmed: 18060375
Handb Exp Pharmacol. 2015;224:483-508
pubmed: 25522999
J Lipid Res. 2004 Jul;45(7):1169-96
pubmed: 15102878
J Crit Care. 2020 Jun;57:197-202
pubmed: 32182565
Intensive Care Med. 2009 Nov;35(11):1877-85
pubmed: 19669126
Ann Intensive Care. 2019 Jun 13;9(1):68
pubmed: 31197574
PLoS One. 2016 May 12;11(5):e0155030
pubmed: 27171436
J Clin Invest. 1978 Dec;62(6):1313-24
pubmed: 372234
Atherosclerosis. 2002 Mar;161(1):1-16
pubmed: 11882312
Ann Intensive Care. 2017 Dec;7(1):60
pubmed: 28589535
Circulation. 1994 Jun;89(6):2533-9
pubmed: 8205661
Crit Care Med. 2005 Aug;33(8):1688-93
pubmed: 16096442
Br J Pharmacol. 2013 Jun;169(3):493-511
pubmed: 23488589
J Intern Med. 2017 May;281(5):518-529
pubmed: 28317295
Crit Care Med. 2005 Jul;33(7):1610-5
pubmed: 16003070
J Lipid Res. 2010 Sep;51(9):2695-705
pubmed: 20495214
Crit Care Med. 2019 Mar;47(3):463-466
pubmed: 30394916
Biol Chem. 2015 Jan;396(1):53-60
pubmed: 25205725
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591